Physician profile
Justin Griffith
NPI 1902434129
$3,328.41
in general payments reported to CMS, 2019-2025
11 companies · $549 in 2025
The $549 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,736 · 2022: $272 · 2023: $318 · 2024: $453 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090 · Travel and Lodging: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.37 |
| Travel and Lodging | $229.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $1,352.59 | 2021-2024 | |
| Stryker Corporation | $1,174.44 | 2021-2025 | Mako, Blueprint Patient Specific Instrumentation, Insignia |
| Medical Device Business Services, INC. | $377.45 | 2021-2025 | Na |
| Kerecis Limited | $114.03 | 2022 | |
| Si-Bone, INC. | $70.42 | 2024 | |
| Medtronic, INC. | $59.19 | 2023 | Aquamantys(Tm) |
| Axogen | $58.95 | 2021 | |
| Ethicon US, LLC | $51.94 | 2024 | Ethicon, Vistaseal |
| Integra Lifesciences Corporation | $30.87 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $22.59 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Globus Medical, INC. | $15.94 | 2024 | Evo Retrograde, Mini Fragment System, Proximal Tibia Plate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.